Elevated CCN1/CYR61 levels is associated with poor prognosis for various cancers including breast cancer [4,5], prostate cancer [6,7], gastric cancer [8], oral squamous cell carcinoma [9], lung cancer [10,11,12], and hepatocellular carcinoma [13]. The gene discussed is CCN1; the disease is hepatocellular carcinoma.